Rchr
J-GLOBAL ID：201901011772927093
Update date: Jun. 25, 2024
MATSUURA Kazuo
マツウラ カズオ | MATSUURA Kazuo
Affiliation and department：
Job title：
Professor
Papers (8)：
-
Hiroko Shimada, Akihiro Fujimoto, Kazuo Matsuura, Shunsuke Kohyama, Asami Nukui, Yuki Ichinose, Aya Asano, Masahiro Ohara, Hiroshi Ishiguro, Akihiko Osaki, et al. Comprehensive prognostic prediction of metastatic breast cancer treated with eribulin using blood-based parameters and ratio. Molecular and Clinical Oncology. 2024. 20. 15
-
Naoki Niikura, Takashi Yamanaka, Hironori Nomura, Kazuhiro Shiraishi, Hiroki Kusama, Mitsugu Yamamoto, Kazuo Matsuura, Kenichi Inoue, Sachiko Takahara, Shosuke Kita, et al. Treatment with trastuzumab deruxtecan in patients with HER2-positive breast cancer and brain metastases and/or leptomeningeal disease (ROSET-BM). NPJ Breast Cancer. 2023. 9. 82
-
松浦 一生, 宮崎 千晶. 乳がん診療最前線の現場から 2023 「mammodite」導入で実現した理想的な教育体制. INNERVISION. 2023. 38. 8. 46-47
-
Kazuo Matsuura, Junji Tsurutani, Kenichi Inoue, Yuko Tanabe, Tetsuhiko Taira, Kaoru Kubota, Tomohide Tamura, Toshiaki Saeki. A phase 3 safety study of fosnetupitant as an antiemetic in patients receiving anthracycline and cyclophosphamide: CONSOLE-BC. Cancer. 2022. 128. 8. 1692-1698
-
Fujimoto A, Matsuura K, Hasebe T, Saeki T. Phyllodes tumour arising in the ectopic axillary breast tissue, mimicking axillary lymphadenopathy. BMJ Case Rep. 2021. 14. 5. e243341
ｍore...
Lectures and oral presentations (10)：
-
Changes in BRCA genetic testing and information management for breast cancer patients
(Human Genetics Asia 2023 (HGA 2023) 2023)
-
脳転移及び/又は髄膜癌腫症を伴うHER2陽性乳癌に対するT-DXdの治療効果 ROSET-BM試験
(第31回日本乳癌学会総会 2023)
-
当院におけるサブタイプ別の術前化学療法症例の検討
(第31回日本乳癌学会総会 2023)
-
BRCA遺伝学的検査の経時的評価とサポート体制
(第8回日本がんサポーティブケア学会 2023)
-
Quality management of sentinel node biopsy cases in coronary disaster
(The 123rd Annual Congress of Japan Surgical Society 2023)
ｍore...
Return to Previous Page
